Dossier
press
news report
Liflex raises $5.25M Series A for anti-aging RNA therapies
Key claim: Biotechnology company Liflex secured $5.25 million in Series A funding to develop RNA therapies targeting aging.
Abstract
News coverage by Dealroom: “Liflex raises $5.25M Series A for anti-aging RNA therapies”. Headline and link only — this finding reports press coverage of a government action, not the primary record.
Why this matters
Biotechnology company Liflex secured $5.25 million in Series A funding to develop RNA therapies targeting aging.